FDA
-
-
-
-
-
-
-
FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease
-
-
-
-
-
-
-
Ra Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Camurus Receives EU Approval for Weekly and Monthly BuvidalĀ® (CAM2038) for Opioid Dependence
-
-
-
-
-
-
-
Camurus and Braeburn Pharmaceuticals Announce Positive Top-line Results from Phase 3 Safety Study of CAM2038
-
323,577 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

